Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gbg Forschungs Gmbh

Clinical trials sponsored by Gbg Forschungs Gmbh, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to stop breast cancer recurrence in High-Risk patients Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New drug aims to stop breast cancer recurrence in High-Risk patients

Disease control Ongoing

This Phase 3 trial tests whether the drug sacituzumab govitecan (Trodelvy) can prevent breast cancer from returning in patients with HER2-negative breast cancer who still have cancer after initial chemotherapy. About 1,332 participants will receive either the new drug or standard…

Phase 3 • Sponsor: GBG Forschungs GmbH • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC